-
Clathrin-Mediated Entry of Type III GCRV
2026-09-12
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to define how genotype III grass carp reovirus enters grass carp kidney cells. Their results support a dynamin-dependent, pH-sensitive clathrin-mediated endocytic route and identify signaling components that may influence infection, while also illustrating the limits of inhibitor-based pathway assignment.
-
TRPV1+ Nerve Stimulation Suppresses Inflammation
2026-09-12
Song et al. show that targeted activation of TRPV1+ peripheral sensory nerves can suppress systemic inflammation through coordinated somatic, autonomic, endocrine, and splenic pathways. The study provides a mechanistic framework for evaluating neuro-immune regulation while emphasizing the need to distinguish neural anti-inflammatory effects from direct receptor-mediated immune stimulation.
-
Palbociclib in Gastric Cancer Assembloid Assays
2026-09-11
Palbociclib and PD0332991 provide a mechanistically focused way to study CDK4/6–Rb control in complex tumor models. This article explains how gastric cancer assembloids can reveal stromal effects that conventional cell-cycle assays may miss.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-09-11
CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for controlled studies of CDK9-dependent transcription elongation, P-TEFb activity, and exploratory HIV-1 propagation inhibition. It is not a pan-CDK reagent, universal cytotoxicity control, or substitute for paper-specific validation of therapeutic or antiviral effects.
-
HBoV1 Replication and RNA Processing: DNMT1–NS1 Axis
2026-09-10
The reference study identifies DNMT1-dependent DNA methylation as a regulatory layer in human bocavirus 1 replication and RNA processing. Its central mechanistic finding is that the viral NS1 protein promotes DNMT1 degradation through the ubiquitin–proteasome pathway, shifting the balance from viral DNA synthesis toward productive RNA processing and protein expression.
-
Palmitic acid: Practical Protocol and QC Guide
2026-09-10
This guide explains how to prepare, document, and quality-check Palmitic acid (SKU N2456) for in vitro lipid and metabolic workflows. It is appropriate for defined solvent-based experiments but should not be used where aqueous solubility or long-term storage of prepared solutions is required.
-
Luminescent ATP Cell Viability Assay Kit I Guide
2026-09-09
Use ATP-dependent luciferase luminescence detection to quantify treatment-related viability changes rapidly, including combination effects in ferroptosis models. This workflow guide shows how to apply the Luminescent ATP Cell Viability Assay Kit I to ciprofloxacin–RSL3 studies while separating viability evidence from mechanistic proof.
-
AM251: A Practical CB1 Receptor Antagonist Workflow
2026-09-09
AM251 enables controlled disruption of CB1 signaling in receptor, synaptic, behavioral, metabolic, and cell-cycle assays. This workflow connects nanomolar pharmacology with practical controls, formulation guidance, and troubleshooting for cannabinoid receptor research.
-
Cisapride in iPSC-CM Cardiotoxicity Workflows
2026-09-08
Cisapride (R 51619) combines 5-HT4 receptor agonism with hERG channel inhibition, making it a useful mechanistic stressor for cardiac electrophysiology research. In iPSC-derived cardiomyocyte assays, it can connect high-content morphology, deep-learning phenotypes, and orthogonal electrophysiology for earlier cardiac arrhythmia risk assessment.
-
WQ-C-401 Blocks PDGFR-Driven Pulmonary Remodeling
2026-09-08
The reference study identifies WQ-C-401 as a selective PDGFR inhibitor that reduced pulmonary vascular remodeling, right ventricular pressure, and inflammatory-cell accumulation in a monocrotaline model of pulmonary arterial hypertension. Its combination of kinome profiling, cell-based signaling assays, and in vivo pathology provides a useful framework for evaluating PDGFR-directed therapies beyond established comparator drugs.
-
Phalloidin B7678: F-Actin Workflow Guide
2026-09-07
Phalloidin B7678 is a cyclic heptapeptide toxin used to bind and stabilize filamentous actin for fixed-sample cytoskeleton visualization. This guide covers preparation, assay setup, quality control, and troubleshooting, while defining why the reagent should not be used for live-cell imaging or experiments that require reversible actin remodeling.
-
Bestatin Hydrochloride: Mechanism & Research Use
2026-09-05
Bestatin hydrochloride, also called Ubenimex, is a research inhibitor of aminopeptidase N/CD13 and aminopeptidase B. Evidence supports its use for aminopeptidase activity, neuronal angiotensin processing, angiogenesis inhibition, and cancer research, while model-specific limits remain important.
-
Monkeypox Replication Inhibitors: Mubritinib Study Insights
2026-09-05
Chiem et al. developed a reporter-virus screening strategy that identified compounds capable of inhibiting vaccinia virus and, for a subset, monkeypox virus replication in vitro. Mubritinib was among the confirmed hits, making TAK 165 a candidate for follow-up antiviral pharmacology while underscoring that the study established phenotypic activity rather than a defined molecular mechanism or therapeutic efficacy.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-09-04
Move from broad protease activity modulation to mechanism-focused validation with an automation-ready compound collection. This workflow shows how to connect biochemical screening, cell-based phenotyping, apoptosis assay design, and resistance studies while controlling DMSO, cytotoxicity, and assay-interference risks.
-
GPR107 Deficiency and Diabetic Nephropathy
2026-09-04
Xu et al. identify GPR107 as a podocyte endocytic regulator that restrains collagen type IV accumulation in diabetic nephropathy. Their findings connect impaired AT1R internalization with Ca2+-CREB signaling, increased collagen synthesis, reduced MMP-2 expression, and worsening glomerular basement membrane pathology.